Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...
MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the proposal of a new approach to solving the Boolean function query problem. This framework starts from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results